High-dose melphalan versus melphalan plus dexamethasone for AL amyloidosis.

Jaccard, A.; Moreau, P.; Leblond, V.; Leleu, X.; Benboubker, L.; Hermine, O.; Récher, C.; Asli, B.; Lioure, B.; Royer, B.; Jardin, F.; Bridoux, F.; Grosbois, B.; Jaubert, J.; Piette, J.; Ronco, P.; Quet, F.; Cogné, M.; Fermand, J.

doi:10.1056/NEJMOA070484

Public

High-Dose Melphalan versus Melphalan plus Dexamethasone for AL Amyloidosis

Shared by NobleBlocks on Sep 12, 2007 • 12:00 AM UTC

Authors:

Arnaud Jaccard

Philippe Moreau

Véronique Leblond

Abstract

BACKGROUND: High-dose chemotherapy followed by autologous hematopoietic stem-cell transplantation has been reported to provide higher response rates and better overall survival than standard chemotherapy in immunoglobulin-light-chain (AL) amyloidosis, but these two strategies have not been compared ...

Subject

Melphalan

Medicine

AL amyloidosis

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!